Lung Cancer 2021, Part 1, an Issue of Thoracic Surgery Clinics

Volume 31-3
Herausgeber: Shamji, Farid M

• Gebundenes Buch

Produktbeschreibung

In this issue of Thoracic Surgery Clinics, guest editor Farid Shamji brings considerable expertise to the topic of Lung Cancer. * Provides in-depth, clinical reviews on Lung Cancer, providing actionable insights for clinical practice. * Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field; Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews.

Produktdetails

• Verlag: Elsevier Health Sciences
• Seitenzahl: 240
• Erscheinungstermin: 6. August 2021
• Englisch
• Abmessung: 257mm x 183mm x 13mm
• Gewicht: 544g
• ISBN-13: 9780323793537
• ISBN-10: 0323793533
• Artikelnr.: 61583467

Inhaltsangabe

How to Design and Foster Thoracic Oncology Multidisciplinary Cancer
Conferences
Guiding Principles in the Management of Synchronous and Metachronous
Primary Non-Small Cell Lung Cancer
When Is It Safe to Operate for Lung Cancer? Selection of Fiscally
Responsible Cardiopulmonary Function Tests for Limited Resection (Wedge
Resection and Segmentectomy), Standard Lobectomy, Sleeve Lobectomy, and
Pneumonectomy
Management of Air Leaks and Residual Spaces Following Lung Resection
Extended Pulmonary Resection by Sleeve Lobectomy and Carinal Pneumonectomy:
Selection and Technique
Role of the Thoracic Radiologist in the Evaluation and Management of Solid
and Subsolid Lung Nodules
Recognition and Management of Acute and Late Complications of
Pneumonectomy: Clinical Cases and Treatment
Constants and Currents in the Education and Training of General Thoracic
Surgeons
Assessment and Rehabilitation of the Compromised Patient Prior to
Thoracotomy
Is Small Cell Lung Cancer a Surgical Disease at the Present Time?
Embolotherapy in Bronchial Hemorrhage
Ethics for Thoracic Surgeons in the Management of Lung Cancer
Oligometastatic Lung Cancer Defined by Biology, Science, and Secondary
Growths
Implications of Adverse Biological Factors and Management of Solitary
Fibrous Tumors of the Pleura
Can Biologic Aggressiveness and Metastatic Potential of Primary Lung Cancer
Be Predicted from Clinical Staging Alone?